Cargando…
Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P(2) and rapamycin
Transient receptor potential mucolipin 1 (TRPML1) is a Ca(2+)-permeable, nonselective cation channel ubiquitously expressed in the endolysosomes of mammalian cells and its loss-of-function mutations are the direct cause of type IV mucolipidosis (MLIV), an autosomal recessive lysosomal storage diseas...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851561/ https://www.ncbi.nlm.nih.gov/pubmed/35131932 http://dx.doi.org/10.1073/pnas.2120404119 |
_version_ | 1784652845362970624 |
---|---|
author | Gan, Ninghai Han, Yan Zeng, Weizhong Wang, Yan Xue, Jing Jiang, Youxing |
author_facet | Gan, Ninghai Han, Yan Zeng, Weizhong Wang, Yan Xue, Jing Jiang, Youxing |
author_sort | Gan, Ninghai |
collection | PubMed |
description | Transient receptor potential mucolipin 1 (TRPML1) is a Ca(2+)-permeable, nonselective cation channel ubiquitously expressed in the endolysosomes of mammalian cells and its loss-of-function mutations are the direct cause of type IV mucolipidosis (MLIV), an autosomal recessive lysosomal storage disease. TRPML1 is a ligand-gated channel that can be activated by phosphatidylinositol 3,5-bisphosphate [PI(3,5)P(2)] as well as some synthetic small-molecule agonists. Recently, rapamycin has also been shown to directly bind and activate TRPML1. Interestingly, both PI(3,5)P(2) and rapamycin have low efficacy in channel activation individually but together they work cooperatively and activate the channel with high potency. To reveal the structural basis underlying the synergistic activation of TRPML1 by PI(3,5)P(2) and rapamycin, we determined the high-resolution cryoelectron microscopy (cryo-EM) structures of the mouse TRPML1 channel in various states, including apo closed, PI(3,5)P(2)-bound closed, and PI(3,5)P(2)/temsirolimus (a rapamycin analog)-bound open states. These structures, combined with electrophysiology, elucidate the molecular details of ligand binding and provide structural insight into how the TRPML1 channel integrates two distantly bound ligand stimuli and facilitates channel opening. |
format | Online Article Text |
id | pubmed-8851561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | National Academy of Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-88515612022-02-18 Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P(2) and rapamycin Gan, Ninghai Han, Yan Zeng, Weizhong Wang, Yan Xue, Jing Jiang, Youxing Proc Natl Acad Sci U S A Biological Sciences Transient receptor potential mucolipin 1 (TRPML1) is a Ca(2+)-permeable, nonselective cation channel ubiquitously expressed in the endolysosomes of mammalian cells and its loss-of-function mutations are the direct cause of type IV mucolipidosis (MLIV), an autosomal recessive lysosomal storage disease. TRPML1 is a ligand-gated channel that can be activated by phosphatidylinositol 3,5-bisphosphate [PI(3,5)P(2)] as well as some synthetic small-molecule agonists. Recently, rapamycin has also been shown to directly bind and activate TRPML1. Interestingly, both PI(3,5)P(2) and rapamycin have low efficacy in channel activation individually but together they work cooperatively and activate the channel with high potency. To reveal the structural basis underlying the synergistic activation of TRPML1 by PI(3,5)P(2) and rapamycin, we determined the high-resolution cryoelectron microscopy (cryo-EM) structures of the mouse TRPML1 channel in various states, including apo closed, PI(3,5)P(2)-bound closed, and PI(3,5)P(2)/temsirolimus (a rapamycin analog)-bound open states. These structures, combined with electrophysiology, elucidate the molecular details of ligand binding and provide structural insight into how the TRPML1 channel integrates two distantly bound ligand stimuli and facilitates channel opening. National Academy of Sciences 2022-02-07 2022-02-15 /pmc/articles/PMC8851561/ /pubmed/35131932 http://dx.doi.org/10.1073/pnas.2120404119 Text en Copyright © 2022 the Author(s). Published by PNAS. https://creativecommons.org/licenses/by/4.0/This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Biological Sciences Gan, Ninghai Han, Yan Zeng, Weizhong Wang, Yan Xue, Jing Jiang, Youxing Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P(2) and rapamycin |
title | Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P(2) and rapamycin |
title_full | Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P(2) and rapamycin |
title_fullStr | Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P(2) and rapamycin |
title_full_unstemmed | Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P(2) and rapamycin |
title_short | Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P(2) and rapamycin |
title_sort | structural mechanism of allosteric activation of trpml1 by pi(3,5)p(2) and rapamycin |
topic | Biological Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851561/ https://www.ncbi.nlm.nih.gov/pubmed/35131932 http://dx.doi.org/10.1073/pnas.2120404119 |
work_keys_str_mv | AT ganninghai structuralmechanismofallostericactivationoftrpml1bypi35p2andrapamycin AT hanyan structuralmechanismofallostericactivationoftrpml1bypi35p2andrapamycin AT zengweizhong structuralmechanismofallostericactivationoftrpml1bypi35p2andrapamycin AT wangyan structuralmechanismofallostericactivationoftrpml1bypi35p2andrapamycin AT xuejing structuralmechanismofallostericactivationoftrpml1bypi35p2andrapamycin AT jiangyouxing structuralmechanismofallostericactivationoftrpml1bypi35p2andrapamycin |